List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 44 studies with search of: "Rubella"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Rubella Susceptibility in Multiparous Women
Conditions: Rubella;   Vaccine
Intervention:
2 Not yet recruiting Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
Conditions: Measles Disease;   Mumps Disease;   Rubella Disease;   Varicella Disease
Interventions: Biological: Priorix-Tetra TM (combined measles-mumps-rubella-varicella vaccine);   Biological: GSK Biologicals' 208136, new formulation
3 Recruiting Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine 208136
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: VarilrixTM;   Biological: PriorixTM;   Biological: GSK Biologicals' vaccine 208136
4 Completed Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Conditions: Measles;   Mumps;   Rubella;   Chickenpox
Intervention: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
5 Completed Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Conditions: Measles;   Mumps;   Rubella;   Chickenpox
Intervention: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
6 Completed Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Conditions: Measles;   Mumps;   Rubella;   Chickenpox
Intervention: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
7 Completed Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MeMuRu-OKA (study vacc);   Biological: MMR, Varicella vacc (control)
8 Completed Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MeMuRu-OKA (study vac);   Biological: MMR, Varicella vacc (control)
9 Completed Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks
10 Active, not recruiting Evaluate Vaccine Agst Chickenpox & a Comb Vaccine Agst 4 Viral Childhood Diseases: Measles, Mumps, Rubella & Chickenpox.
Conditions: Measles;   Mumps;   Rubella;   Chickenpox
Interventions: Biological: Priorix-tetra™;   Biological: Priorix™;   Biological: Varilrix™
11 Recruiting Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine
Conditions: Measles;   Mumps;   Rubella;   Hepatitis A
Interventions: Biological: Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella;   Biological: Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine;   Biological: Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella
12 Completed Long-Term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMRV;   Biological: MMR (Priorix®);   Biological: Varicella (Varilrix®)
13 Completed Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR vaccine (Priorix)
14 Suspended A Study of ProQuad in Healthy Korean Children
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live;   Biological: Comparator: MMR II + Varivax
15 Completed Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly
Conditions: Varicella;   Measles;   Mumps;   Rubella;   Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B;   Haemophilus Infections
Intervention: Biological: ProQuad® and Infanrix® hexa
16 Terminated Immune Responses to Two Dose Varivax +/- MMR-II
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMR-II;   Biological: Pro-Quad;   Biological: Varivax
17 Completed ProQuad® rHA Safety
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: ProQuad® manufactured with rHA
18 Terminated Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention:
19 Completed
Has Results 		Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study
Conditions: Hepatitis A;   Measles;   Mumps;   Rubella;   Chickenpox
Interventions: Biological: VAQTA®;   Biological: ProQuad
20 Completed Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: MeMuRu-OKA (study vaccine)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services